Research of the domestic market of drugs for the treatment of HIV infection
DOI:
https://doi.org/10.14739/2409-2932.2023.1.272611Keywords:
research, drug, marketing, HIV infection, antiretroviral drugsAbstract
The aim of the research is to study the domestic market of medicines for the treatment of HIV infection to optimize the drug supply of the target group of patients.
Materials and methods. Electronic sources of information (State Register of Medicines of Ukraine, Compendium-online, Tabletki.ua) were used to achieve the goal. System-analytical, mathematical-statistical, and comparative methods of analysis were used.
Results. The study of the assortment of drugs for the treatment of HIV infection showed the heterogeneity of the specified segment of the pharmaceutical market of Ukraine: there are solid and liquid dosage forms, both original and generic. The analysis of the company structure made it possible to establish that the national market of drugs for the treatment of HIV infection was dominated by foreign manufacturers (95.93 %), the largest share of which was pharmaceutical companies from India (67.07 %).
The competitiveness of pharmaceutical firms supplying drugs for the treatment of HIV infection was studied. It was established that the firm Janssen-Silag S.p.A., Italy, occupied the most stable position in the studied market segment. A qualitative analysis of the mentioned medicines was carried out. The most effective and rational of them were determined.
Conclusions. A study of the domestic market of drugs for the treatment of HIV infection was conducted. The assortment and brand structure of this market segment was determined. The level of competitiveness of the above-mentioned pharmaceutical companies were analyzed, and the most successful of them were identified. At the same time, it was established that domestic pharmaceutical companies supply only 4.07 % of drugs of two out of five groups according to the ATS classification to this segment of the market. In connection with this, the development of new drugs of the specified action and the development of their production in Ukraine is important.
References
Public Health Center of the Ministry of Health of Ukraine. (2022). Statystyka z VIL/SNIDu [Statistics on HIV/AIDS]. https://phc.org.ua/kontrol-zakhvoryuvan/vilsnid/statistika-z-vilsnidu
United Nations Development Programme. (2022, Decemder 1). SNID i viina: yak Ukraina boretsia z VIL/SNIDom u 2022 rotsi [AIDS and war: how Ukraine is fighting HIV/AIDS in 2022]. https://www.undp.org/uk/ukraine/news/snid-i-viyna-yak-ukrayina-boretsya-z-vil/snidom-u-2022-rotsi
Ilinska, I. F. (n.d.). Populiarno pro VIL-infektsiiu [Popular about HIV-infection] Natsionalnyi instytut ftyziatrii i pulmonolohii im. V. H. Yanovskoho. [in Ukrainian]. http://www.ifp.kiev.ua/doc/people/vil-pop/vil-pop6.htm
Ministry of Health of Ukraine. (2010, July 12). Pro zatverdzhennia klinichnoho protokolu antyretrovirusnoi terapii VIL-infektsii u doroslykh ta pidlitkiv [On the approval of the clinical protocol of antiretroviral therapy of HIV infection in adults and adolescents (No. 551)]. https://zakon.rada.gov.ua/rada/show/v0551282-10#n14
Posilkina, O. V., & Demchenko, N. V. (2014). Metodolohichni i metodychni aspekty otsinky konkurentospromozhnosti farmatsevtychnykh pidpryiemstv. [Methodological and methodical aspects of pharmaceutical companies competitiveness assessment]. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, (2), 28-35. [in Ukrainian].
Bushueva, I. V., Karpova, O. I., Demchenko, V. A., & Makovik, Yu. V. (2004). Metodicheskie podkhody k opredeleniyu ustoichivosti tovarnoi i konkurentnoi pozitsii farmatsevticheskoi firmy v usloviyakh rynka i ogranichennoi roli gosudarstva [Methodological approaches to de-termining the stability of the commodity and competitive position of a pharmaceutical company in market conditions and the limited role of the state]. Zaporozhye Medical Journal, 2(1), 109-111. [in Russian].
Balabanova, L. V., Kholod, V. V., & Balabanova, I. V (2012). Marketynh pidpryiemstva [Enterprise marketing]. Kyiv: Tsentr uchbovoi literatury. [in Ukrainian].
Dmytrenko, H. A., Anufriieva, O. L., Burlaienko, T. I., & Medvid, V. V. (2016). Kvalimetriia v upravlinni: humanistychnyi kontekst [Qualimetrics in management: a humanistic context]. Kyiv: Vydavnytstvo "Ahrarna osvita". [in Ukrainian].
Kuts, V. R., Stoliarchuk, P. H., & Druziuk, V. M. (2012). Kvalimetriia [Qualimetrics]. Lviv. [in Ukrainian].
Kompendium [Compendium]. http://compendium.com.ua/
Ministry of Health of Ukraine. (n.d.). Derzhavnyi reiestr likarskykh zasobiv Ukrainy [State register of medicines of Ukraine]. http://www.drlz.kiev.ua
Tabletki.ua. [website]. https://tabletki.ua/uk/
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
